It is widely accepted that activation of NMDA-type glutamate receptors (NMDARs) is required for the strengthening and weakening of cortical synaptic connections during visual development. NMDAR dysfunction has been implicated in a wide variety of neurological disease states such as epilepsy, schizophrenia, stroke, and neuropathic pain. Most research has focused on the role of NMDARs postsynaptically. Recently it has been found that neurons in the visual cortex also express NMDARs that can modify presynaptic functions (preNMDARs). PreNMDARs are expressed early in cortical development and modulate the release of neurotransmitter through mechanisms such as spike-timing dependent long-term depression. Studies have also implicated preNMDARs in disease states such as epilepsy. Despite this knowledge about preNMDARs, it is not clear what allows for their function and developmental regulation. Unlike postsynaptic NMDARs, preNMDARs in the developing neocortex do not require the coincident binding of glutamate and depolarization to be active. Instead, they are tonically active and therefore able to increase the release of neurotransmitter in the absence of depolarization. PreNMDARs are also sharply downregulated in the neocortex following postnatal day 20. I hypothesize that a NMDAR subunit endows preNMDARs with the ability to be tonically active and is essential for their developmental regulation. I will therefore determine: 1) The NMDAR subunit composition of preNMDARs early in life which allows for their tonic activity, 2) The mechanism by which preNMDAR subunits allow for tonic activity, and 3) If these subunits are required for timing-dependent long- term depression and for preNMDARs to modulate action potential-driven release. To accomplish this, I will use electrophysiology, electron microscopy, and biochemical fractionation on mice which lack specific NMDAR subunits. These studies will demonstrate the molecular composition of preNMDARs and the mechanism by which they function. Therefore, these experiments are expected to provide new molecular targets for therapies to treat epilepsy, stroke, neuropathic pain, and schizophrenia and may clarify the mechanism by which current NMDAR-mediated therapies act.

Public Health Relevance

NMDA receptors (NMDARs) are critically important for learning and memory, and their dysfunction contributes to a myriad of neurological disorders, including schizophrenia, epilepsy, pain, and stroke. This proposal will expand the knowledge of these receptors by determining their composition and function in a previously unstudied cellular compartment. Therefore, these experiments may reveal new therapeutic targets for neurological disorders and may clarify the mechanism by which current NMDAR-mediated therapies act.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31MH091817-03
Application #
8468943
Study Section
Special Emphasis Panel (ZRG1-F03A-F (20))
Program Officer
Rosemond, Erica K
Project Start
2011-06-29
Project End
2014-02-28
Budget Start
2013-06-29
Budget End
2014-02-28
Support Year
3
Fiscal Year
2013
Total Cost
$19,656
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Physiology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Mabb, Angela M; Je, H Shawn; Wall, Mark J et al. (2014) Triad3A regulates synaptic strength by ubiquitination of Arc. Neuron 82:1299-316
Larsen, Rylan S; Smith, Ikuko T; Miriyala, Jayalakshmi et al. (2014) Synapse-specific control of experience-dependent plasticity by presynaptic NMDA receptors. Neuron 83:879-93